Recruiting COVID-19 Studies in Sacramento
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults
The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-19 Vaccine, mRNA; 2024-2025 Formula), a currently a...
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19....
About COVID-19 Clinical Trials in Sacramento
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that primarily affects the respiratory system. Long COVID (PASC) involves persistent symptoms weeks or months after initial infection. Treatment includes antiviral medications, monoclonal antibodies, and supportive care.
There are currently 2 covid-19 clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 10,290 participants. Research is being sponsored by CyanVac LLC, Ansun Biopharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
COVID-19 Clinical Trials in Sacramento — FAQ
Are there covid-19 clinical trials in Sacramento?
Yes, there are 2 covid-19 clinical trials currently recruiting in Sacramento, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Sacramento?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.
Are clinical trials in Sacramento free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.
What covid-19 treatments are being tested?
The 2 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for covid-19.
Data updated March 2, 2026 from ClinicalTrials.gov